REVANESSE references stocked by ALLPARA for professional use, sourced direct and certified on every shipment.
Revanesse Shape™+
Revanesse Shape+ is a colourless, odourless and transparent aqueous gel of synthetic origin from Prollenium Medical Technologies in Aurora, Canada, indicated for treating lipoatrophy and medium to deep facial rhytides. Its injection target is the middle part of the dermis layer, and the implant lasts 6 to 12 months on average. The gel is made of 25 mg/mL of hyaluronic acid, cross-linked with BDDE, and 0.3% lidocaine in phosphate-buffered saline, for professional use only. Every box holds two 1.2 mL syringes with up to two sterilised 27G needles.
主なメリット: Revanesse Shape™+
- Cross-linked hyaluronic acid 25 mg/mL with 0.3% lidocaine for injection comfort
- Indicated for medium to deep facial rhytides and for lipoatrophy
- Placed in the middle part of the dermis layer
- Implantation life averages 6 to 12 months
- Supplied as two 1.2 mL pre-filled syringes with up to two sterilised 27G needles
- BDDE cross-linked in phosphate-buffered saline
- CE marked 0653 for the syringe, with CE 0123 needles
適応と専門的な使用
主な適応
- Medium to deep facial rhytides
- Lipoatrophy
専門的な使用
For professional use. Revanesse Shape+ should only be injected by or under the direct supervision of qualified physicians trained in the proper injection technique for filling facial wrinkles, and is not for retail sale or self-administration. It is placed in the middle part of the dermis layer. The area must be thoroughly disinfected and injection performed under sterile conditions; bring the product to room temperature for 30 minutes beforehand, prime the syringe until a small drop appears at the needle tip, and inject slowly with the least pressure necessary. If the skin blanches, stop immediately and massage until normal colour returns. It must not be injected into an area already containing another filler or a permanent implant, and must not contact quaternary ammonium salts such as benzalkonium chloride. Store between 2 and 25 degrees Celsius, protected from direct sunlight and freezing.
施術部位
- Face
対象となる患者
For adult patients seeking correction of medium to deep facial rhytides or of lipoatrophy, as assessed by a qualified physician. Because it contains lidocaine, it is contraindicated in patients with hypersensitivity to any amide-type local anaesthetic. Further contraindications include hypertrophic scarring, acne or other inflammatory skin disease, acute or chronic skin disease at or near the injection site, auto-immune disorders or immunotherapy, multiple severe allergies, coagulation defects or anti-coagulation therapy, sensitivity to hyaluronic acid, and unattainable expectations. It contains trace amounts of gram-positive bacterial proteins and is contraindicated in patients allergic to such material. It must not be used during pregnancy or lactation, in anyone under 18, or in conjunction with laser, intense pulsed light, chemical peeling or dermabrasion.
作用の仕組み: Revanesse Shape™+
Shape+ is a cross-linked hyaluronic acid gel that occupies volume in the dermis where it is placed, correcting medium to deep rhytides and the volume loss of lipoatrophy. Because it is placed in the middle part of the dermis rather than superficially, how long it lasts depends on the depth and location of the injection, which is why it lasts 6 to 12 months rather than a fixed period. The 0.3% lidocaine is present for injection comfort, which makes hypersensitivity to amide-type anaesthetics an outright contraindication.
Allparaで注文する理由
Allparaは、正規品で検証済みの REVANESSE 製品を厳選されたサプライヤーから提供し、完全なロットトレーサビリティと専門家によるサポートを備えています。CE認証製品、EU倉庫からのEU全域への迅速な配送、競争力のある業務用価格で、クリニックと美容医療の専門家にサービスを提供しています。私たちが重視するのは患者様の安全、満足、そして結果です。安心してご利用いただけるよう、専任のアフターサポートをご用意しています。
よくある質問
How does Revanesse Shape™+ differ from Revanesse Sculpt™+?
They share the same specification: 25 mg/mL cross-linked hyaluronic acid with 0.3% lidocaine, two 1.2 mL syringes with 27G needles, placed in the middle part of the dermis for medium to deep facial rhytides and lipoatrophy, lasting 6 to 12 months.
What should a practitioner do if the skin blanches during injection?
Stop the injection immediately and massage the area until the skin returns to its normal colour. Blanching can signal intravascular placement, which has been associated with embolisation, vision impairment, blindness, skin necrosis and stroke.
その他の製品: Prollenium Medical Technologies
Clinic alternatives
Pick up where you left off
Revanesse Shape™+
Revanesse Shape+ is a colourless, odourless and transparent aqueous gel of synthetic origin from Prollenium Medical Technologies in Aurora, Canada, indicated for treating lipoatrophy and medium to deep facial rhytides. Its injection target is the middle part of the dermis layer, and the implant lasts 6 to 12 months on average. The gel is made of 25 mg/mL of hyaluronic acid, cross-linked with BDDE, and 0.3% lidocaine in phosphate-buffered saline, for professional use only. Every box holds two 1.2 mL syringes with up to two sterilised 27G needles.
主なメリット: Revanesse Shape™+
- Cross-linked hyaluronic acid 25 mg/mL with 0.3% lidocaine for injection comfort
- Indicated for medium to deep facial rhytides and for lipoatrophy
- Placed in the middle part of the dermis layer
- Implantation life averages 6 to 12 months
- Supplied as two 1.2 mL pre-filled syringes with up to two sterilised 27G needles
- BDDE cross-linked in phosphate-buffered saline
- CE marked 0653 for the syringe, with CE 0123 needles
適応と専門的な使用
主な適応
- Medium to deep facial rhytides
- Lipoatrophy
専門的な使用
For professional use. Revanesse Shape+ should only be injected by or under the direct supervision of qualified physicians trained in the proper injection technique for filling facial wrinkles, and is not for retail sale or self-administration. It is placed in the middle part of the dermis layer. The area must be thoroughly disinfected and injection performed under sterile conditions; bring the product to room temperature for 30 minutes beforehand, prime the syringe until a small drop appears at the needle tip, and inject slowly with the least pressure necessary. If the skin blanches, stop immediately and massage until normal colour returns. It must not be injected into an area already containing another filler or a permanent implant, and must not contact quaternary ammonium salts such as benzalkonium chloride. Store between 2 and 25 degrees Celsius, protected from direct sunlight and freezing.
施術部位
- Face
対象となる患者
For adult patients seeking correction of medium to deep facial rhytides or of lipoatrophy, as assessed by a qualified physician. Because it contains lidocaine, it is contraindicated in patients with hypersensitivity to any amide-type local anaesthetic. Further contraindications include hypertrophic scarring, acne or other inflammatory skin disease, acute or chronic skin disease at or near the injection site, auto-immune disorders or immunotherapy, multiple severe allergies, coagulation defects or anti-coagulation therapy, sensitivity to hyaluronic acid, and unattainable expectations. It contains trace amounts of gram-positive bacterial proteins and is contraindicated in patients allergic to such material. It must not be used during pregnancy or lactation, in anyone under 18, or in conjunction with laser, intense pulsed light, chemical peeling or dermabrasion.
作用の仕組み: Revanesse Shape™+
Shape+ is a cross-linked hyaluronic acid gel that occupies volume in the dermis where it is placed, correcting medium to deep rhytides and the volume loss of lipoatrophy. Because it is placed in the middle part of the dermis rather than superficially, how long it lasts depends on the depth and location of the injection, which is why it lasts 6 to 12 months rather than a fixed period. The 0.3% lidocaine is present for injection comfort, which makes hypersensitivity to amide-type anaesthetics an outright contraindication.
Allparaで注文する理由
Allparaは、正規品で検証済みの REVANESSE 製品を、完全なロットトレーサビリティ、CE認証在庫、EU全域への迅速な配送、専門的なアフターサポートとともに提供しています。
よくある質問
How does Revanesse Shape™+ differ from Revanesse Sculpt™+?
They share the same specification: 25 mg/mL cross-linked hyaluronic acid with 0.3% lidocaine, two 1.2 mL syringes with 27G needles, placed in the middle part of the dermis for medium to deep facial rhytides and lipoatrophy, lasting 6 to 12 months.
What should a practitioner do if the skin blanches during injection?
Stop the injection immediately and massage the area until the skin returns to its normal colour. Blanching can signal intravascular placement, which has been associated with embolisation, vision impairment, blindness, skin necrosis and stroke.